Abstract
The duration of action of adenosine A2A receptor (A2A) agonists is critical for their clinical efficacy, and we sought to better understand how this can be optimized. The in vitro temporal response profiles of a panel of A2A agonists were studied using cAMP assays in recombinantly (CHO) and endogenously (SH-SY5Y) expressing cells. Some agonists (e.g., 3cd; UK-432,097) but not others (e.g., 3ac; CGS-21680) demonstrated sustained wash-resistant agonism, where residual receptor activation continued after washout. The ability of an antagonist to reverse pre-established agonist responses was used as a surrogate read-out for agonist dissociation kinetics, and together with radioligand binding studies suggested a role for slow off-rate in driving sustained effects. One compound, 3ch, showed particularly marked sustained effects, with a reversal t1/2 > 6 hours and close to maximal effects that remained for at least 5 hours after washing. Based on the structure-activity relationship of these compounds, we suggest that lipophilic N6 and bulky C2 substituents can promote stable and long-lived binding events leading to sustained agonist responses, although a high compound logD is not necessary. This provides new insight into the binding interactions of these ligands and we anticipate that this information could facilitate the rational design of novel long-acting A2A agonists with improved clinical efficacy.
Footnotes
- Received June 10, 2016.
- Accepted October 28, 2016.
This work was funded by AstraZeneca as part of the Innovative Medicines Initiative Joint Undertaking under K4DD, grant agreement no. 115366, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme [FP7/2007-2013] and EFPIA companies’ in kind contribution.
↵This article has supplemental material available at molpharm.aspetjournals.org.
- Copyright © 2016 by The Author(s)
This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.